• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,394.87 -113.74
(-1.08%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Zim Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541400
INE518E01015
53.0292332
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZIMLAB
139.02
610.46
EPS(TTM)
Face Value()
Div & Yield %
0.82
10
0
 

Artson standalone net profit rises 460.00% in the March 2026 quarter
Apr 28,2026
Net profit of Artson rose 460.00% to Rs 3.36 crore in the quarter ended March 2026 as against Rs 0.60 crore during the previous quarter ended March 2025. Sales declined 24.40% to Rs 38.75 crore in the quarter ended March 2026 as against Rs 51.26 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 10.88 crore in the year ended March 2026 as against net profit of Rs 3.48 crore during the previous year ended March 2025. Sales rose 44.06% to Rs 163.58 crore in the year ended March 2026 as against Rs 113.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales38.7551.26 -24 163.58113.55 44
OPM %14.327.65 --3.37-2.20 -
PBDT3.911.34 192 -13.677.19 PL
PBT3.300.79 318 -16.194.79 PL
NP3.360.60 460 -10.883.48 PL